Research
Hormonal
EPA reduces cardiovascular risk through multiple mechanisms including lowering triglycerides, reducing inflammation, stabilizing cell membranes, and improving endothelial function, distinct from DHA.
EPA works by lowering triglycerides, reducing inflammation, and stabilizing cell membranes, which together protect the heart.
GoodSupportsHIGH confidence
This clinical benefit likely arises from multiple molecular mechanisms discussed in this review. Indeed, human plaques readily incorporate EPA, which may render them less likely to trigger clinical events.
Why this rating
Review of multiple studies and mechanistic data.
Source
Emerging Mechanisms of Cardiovascular Protection for the Omega-3 Fatty Acid Eicosapentaenoic Acid
R. Preston Mason et al. · Arteriosclerosis Thrombosis and Vascular Biology · 2020
DOI 10.1161/atvbaha.119.313286
narrative_reviewCited 389×
Read the paper DOI resolved against Crossref · corpus check 2026-06-10
Related findings · Hormonal
- Initial treatment for type 2 diabetes should be a combination of metformin and either an SGLT-2 inhibitor or a GLP-1 receptor agonist to achieve cardiorenal protection, rather than monotherapy or older agents like sulfonylureas.Strong
- For patients with specific monogenic obesity syndromes (leptin deficiency, POMC/PCSK1/LEPR mutations), targeted pharmacotherapy (recombinant leptin or setmelanotide) is highly effective and should be prioritized, unlike in polygenic obesity.Strong
- Continued weekly administration of 2.4 mg subcutaneous semaglutide prevents weight regain and promotes further weight loss in adults with overweight or obesity, whereas switching to placebo results in significant weight regain.Strong
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →